文献类型：期刊文献

英文题名：The top-100 most cited articles of biomarkers in congenital heart disease: a bibliometric analysis

作者：Yi, Kang[1,2,3];Xu, Jian-Guo[1];Yang, Ke-Lu[4];Zhang, Xin[3,5];Ma, Long[5];You, Tao[2,3];Tian, Jin-Hui[1,3,6]

第一作者：Yi, Kang

通信作者：Tian, JH[1];You, T[2]

机构：[1]Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, 199 Donggang West Rd, Lanzhou 730000, Gansu, Peoples R China;[2]Gansu Prov Hosp, Dept Cardiovasc Surg, 204 Donggang West Rd, Lanzhou 730000, Gansu, Peoples R China;[3]Gansu Int Sci & Technol Cooperat Base Diag & Trea, Lanzhou, Peoples R China;[4]KU Leuven Univ Leuven, Acad Ctr Nursing & Midwifery, Dept Publ Hlth & Primary Care, Leuven, Belgium;[5]Gansu Univ Chinese Med, Sch Clin Med 1, Lanzhou, Peoples R China;[6]Lanzhou Univ, Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou, Peoples R China

第一机构：Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, 199 Donggang West Rd, Lanzhou 730000, Gansu, Peoples R China

通信机构：[1]corresponding author), Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, 199 Donggang West Rd, Lanzhou 730000, Gansu, Peoples R China;[2]corresponding author), Gansu Prov Hosp, Dept Cardiovasc Surg, 204 Donggang West Rd, Lanzhou 730000, Gansu, Peoples R China.

年份：2022

卷号：11

期号：5

起止页码：1700

外文期刊名：ANNALS OF PALLIATIVE MEDICINE

收录：;Scopus(收录号：2-s2.0-85130721685);WOS:【SCI-EXPANDED(收录号:WOS:000737457900001)】；

基金：This study was supported by the Gansu ProvinceScience and Technology Plan Funded Project under project number 20CX4ZA027 & 20CX9ZA112, Natural Science Foundation of Gansu Province under project number 21JR1RA027, and Health industry scientific research project of Gansu Province under project number GSWSKY2016-04.

语种：英文

外文关键词：Congenital heart defect; biomarkers; bibliometric analysis; citation analysis; visualized maps

摘要：Background: Biomarkers have played an important role in the treatment and management of patients with congenital heart disease (CHD). The 100 most frequently cited articles addressing the possible role of biomarkers assessment in treatment and outcomes in patients with CHD were reviewed. Methods: The Web of Science Core Collection database was selected as the database for this selection of publications. CiteSpace 5.7.R1 and VOSviewer 1.6.9 were used to analyze the information. Results: A total of 877 articles referencing cardiac biomarkers and CHD were identified in the search period January 1980-June 2020. After screening, the top 100 most cited articles were finally determined. These articles were published in 56 journals, of which the Pediatric Cardiology published the most articles (n=8). Countries collaboration involved a total of 10 countries, and the visualized map indicated the USA had the strongest collaboration network. Related topics of future research will still focus on prevention, general condition evaluation, surgical prognosis evaluation, and application of natriuretic peptide in CHD. Conclusions: We conducted an insight to acquainting characteristics of highly cited publications of biomarkers in CHD and highlighting the research subjects, global research trends, and network collaboration between countries. Related topics of frontiers will focus on: (I) the application of natriuretic peptide, (II) the diagnostic and prognostic value of genes and their related transcriptional translation agents, (III) the use of biomarkers to evaluate and predict the postoperative injury caused by extracorporeal circulation, (IV) and the application of other biomarkers (such as oxidative stress, homocysteine, and thrombosis) to assess and predict damage circumstance.